Valuation: DOD Biotech

Market Cap 279M 8.33M 7.47M 6.83M 6.23M 11.74M 783M 12.11M 82.27M 32.8M 418M 31.25M 30.58M 1.32B P/E 2024
-4.69x
P/E 2025 12.2x
Enterprise Value 59.58M 1.78M 1.59M 1.46M 1.33M 2.5M 167M 2.58M 17.55M 7M 89.1M 6.67M 6.52M 281M EV / Sales 2024
0.86x
EV / Sales 2025 0.82x
Free-Float
61.22%
Yield 2024 *
-
Yield 2025 3.09%
1 day-8.82%
1 week-18.42%
Current month-18.42%
1 month-23.46%
3 months-42.59%
6 months-63.95%
Current year-61.73%
1 week 0.62
Extreme 0.62
0.72
1 month 0.62
Extreme 0.62
0.85
Current year 0.56
Extreme 0.56
2.06
1 year 0.56
Extreme 0.56
2.06
3 years 0.56
Extreme 0.56
3.96
5 years 0.56
Extreme 0.56
12.2
10 years 0.56
Extreme 0.56
16.4
Manager TitleAgeSince
Chief Executive Officer 47 01/12/2022
Director of Finance/CFO 44 01/01/2014
Chief Administrative Officer 48 23/03/2021
Director TitleAgeSince
Director/Board Member 54 04/12/2015
Director/Board Member 67 24/12/2015
Director/Board Member 44 01/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
-8.82%-18.42%-63.53%-83.77% 8.33M
-1.58%+1.36%+8.51%-13.82% 269B
-1.20%+1.66%+15.46%-3.61% 83.57B
-2.10%+2.44%-14.17%+18.07% 48.14B
-0.78%-0.68%+25.98%+557.35% 44.99B
+0.37%+7.53%+4.38%-5.02% 35.79B
-0.71%-9.02%+22.80%-2.97% 33.3B
+0.36%+2.64%-5.77%-6.09% 30.69B
+1.29%+4.31%+15.24%+13.95% 29.79B
-2.80%+1.11%+1.36%-25.63% 29.13B
Average -1.60%+0.05%+1.03%+44.85% 60.48B
Weighted average by Cap. -1.17%+1.39%+8.77%+34.92%

Financials

2024 2025
Net sales 662M 19.74M 17.7M 16.18M 14.77M 27.83M 1.86B 28.7M 195M 77.77M 990M 74.09M 72.5M 3.13B 621M 18.52M 16.61M 15.18M 13.86M 26.11M 1.74B 26.93M 183M 72.97M 929M 69.52M 68.03M 2.93B
Net income -159M -4.75M -4.26M -3.89M -3.55M -6.7M -447M -6.91M -46.94M -18.72M -238M -17.83M -17.45M -752M 59.59M 1.78M 1.59M 1.46M 1.33M 2.5M 167M 2.58M 17.55M 7M 89.11M 6.67M 6.53M 281M
Net Debt -177M -5.28M -4.73M -4.33M -3.95M -7.44M -496M -7.68M -52.15M -20.8M -265M -19.81M -19.39M -836M -220M -6.55M -5.87M -5.37M -4.9M -9.23M -616M -9.52M -64.71M -25.8M -329M -24.58M -24.06M -1.04B
Projected Income Statement - Annual - DOD Biotech
Logo DOD Biotech
DOD Biotech Public Company Limited is a Thailand-based company that is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The Company’s segments include supplementary business and others. Its product categories include dietary supplements for beauty and dietary supplement products for health. It offers products in the form of capsules, gels, jellies, powders, shot drinks, softgels, tablets, probiotics, gummies, and direct-to-mouth. It uses ingredients and raw materials such as Olive Extract, Acai Berry Extract, Saffron Extract, Maqui Berry Extract, Ginkgo Biloba Extract, Quercetin Extract, Beetroot Extract, Kiwi Powder, Rosa centifolia Extract, Persimmon Extract, and Dragon Fruit Extract. The Company’s subsidiaries are DOD Healthy Life Co., Ltd., DOD Sale Power Co., Ltd., Siam Herbal Tech Co., Ltd., A Metaverse Co., Ltd., and DOD Infinite Co., Ltd. The manufacturing plant is located at Mueang Samut Sakhon, Samut Sakhon.
Employees
-
Date Price Change Volume
06/11/26 THB 0.6200 -8.82% 399,574
05/11/26 THB 0.6800 -1.45% 60,963
04/11/26 THB 0.6900 0.00% 15,800
03/11/26 THB 0.6900 -1.43% 67,458
02/11/26 THB 0.7000 -7.89% 455,100